Funding · Company

Gilgamesh Pharma Inc.

New York, NYBiotech & Pharma

Gilgamesh Pharma Inc. of New York, NY has disclosed $60M across 1 Form D offering filed with the SEC on Mar 24, 2026.

$60M

Total disclosed

Form D offering

2025

Incorporated

Offerings on file

Each amount is as reported on that filing, cumulative across its own amendments. Newest first.

$60M

Form D · Mar 24, 2026 ↗

Q1 2026

Filing details

HeadquartersNew York, NYIndustryBiotech & Pharma (Pharmaceuticals)Incorporated2025SEC CIK0002107396Offerings on file1

Links

All SEC filings for this company ↗ gilgameshpharma.com ↗ Startups in New York → More biotech & pharma raises →

Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →